Yüklüyor......
Denosumab Induced Severe Prolonged Hypocalcemia in Metastatic Prostate Cancer
Background: Denosumab is a RANK-l inhibitor that, in addition to the treatment of osteoporosis, is used in patients with advanced cancer and metastatic bone disease to prevent skeletal-related events. Although denosumab is generally safe and effective, it can cause hypocalcemia which in some patient...
Kaydedildi:
| Yayımlandı: | J Endocr Soc |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089690/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.385 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|